Weight loss can shift levothyroxine requirements rapidly, and what looks like a GLP-1 side effect may actually be thyroid medication overmedication or undermedication
As long as water drains as fast as it comes in, there's no overflow
Regulatory Notice: Regulatory status and approved indications vary by jurisdiction
For women with personal or family histories of hormone-sensitive cancers, I would consider these peptides contraindicated until long-term safety data become available
however, the primary licensed indication for Wegovy in the UK remains chronic weight management, and patients should discuss any cardiovascular considerations with their clinician
There is no specific cause, but there are a variety of risk factors, such as stress, anxiety and depression